- Company announces increased
quarterly dividend of 15.4% -
LUNENBURG, NS, Nov. 8, 2023
/CNW/ - High Liner Foods Incorporated (TSX: HLF) ("High Liner
Foods" or "the Company"), a leading North American value-added
frozen seafood company, today announced financial results for the
thirteen and thirty-nine weeks ended September 30, 2023.
"We continued to deliver year-over-year volume growth in the
third quarter driven by market share gains across our foodservice
and Canadian retail business and continued strong execution in
priority growth segments and increased market share," said
Paul Jewer, Interim Chief Executive
Officer for High Liner Foods. "However, the pricing and promotional
activity required to support sales in the current economic climate,
along with the impact of ongoing industry-wide elevated inventory
levels, led to a decline in Adjusted EBITDA for the quarter.
Looking ahead, the steps we are taking to enhance our value
offering and drive efficiencies across our operations will allow us
to mitigate the impact of external headwinds on our business as we
move into 2024."
Mr. Jewer added, "Our balance sheet strengthened during the
quarter with reduced leverage to 3.1x as a result of significant
cash flow from our operations of $54
million. We will continue to focus on improving cash flow
and utilize the benefits of our diversification, scale, and
relationships to support our customers and create the conditions
for continued profitable growth for our business."
Dividend Increase
The Company's Board of Directors approved a quarterly dividend
of CAD$0.15 per share on the
Company's common shares, payable on December 15, 2023 to
holders of record on December 1, 2023. The quarterly dividend
of CAD$0.15 per share represents a
CAD $0.02 cents increase from the
CAD$0.13 per share quarterly dividend
paid during the third quarter of 2023 and reflects the Board's
continued confidence in the Company's operations.
"The dividend increase announced today recognizes the Company's
strong cash flow position." said Robert
Pace, Chair of the Board of Directors.
Key financial results, reported in U.S. dollars ("USD"), for the
thirteen weeks ended September 30, 2023, or the third quarter
of 2023, are as follows (unless otherwise noted, all comparisons
are relative to the third quarter of 2022):
- Sales volume increased by 0.6 million pounds, or 1.0%, to 61.0
million pounds compared to 60.4 million pounds and sales decreased
by $11.5 million, or 4.2%, to
$259.7 million compared to
$271.2 million;
- Gross profit decreased by $7.1
million, or 12.5%, to $49.6
million compared to $56.7
million, and gross profit as a percentage of sales decreased
to 19.1% compared to 20.9%;
- Adjusted EBITDA(1) decreased by $4.8 million, or 19.4%, to $20.0 million compared to $24.8 million, and Adjusted EBITDA as a
percentage of sales decreased to 7.7% compared to 9.1%;
- Net income decreased by $4.5
million, or 45.0%, to $5.5
million compared to $10.0
million and diluted earnings per share ("EPS") decreased to
$0.16 per share, compared to
$0.28 per share;
- Adjusted Net Income(1) decreased by $9.4 million, or 65.7% to $4.9 million compared to $14.3 million and Adjusted Diluted
EPS(1) decreased to $0.14
per share compared to $0.41 per
share; and
- Net Debt(1) to Rolling Twelve-Month Adjusted
EBITDA(1) was 3.1x at September
30, 2023 compared to 3.7x at the end of Fiscal 2022 and 3.2x
at October 1, 2022. This ratio
increased during the second half of Fiscal 2022 due to increased
investment in inventory.
Key financial results, reported in U.S. dollars ("USD"), for the
thirty-nine weeks ended September 30, 2023, or Fiscal 2023,
are as follows (unless otherwise noted, all comparisons are
relative to the thirty-nine weeks ended October 1, 2022, or
"Fiscal 2022"):
- Sales volume increased by 4.9 million pounds, or 2.5%, to 197.4
million pounds compared to 192.5 million pounds and sales increased
by $23.8 million, or 2.9%, to
$843.2 million compared to
$819.4 million;
- Gross profit decreased by $5.1
million, or 2.9%, to $170.0
million compared to $175.1
million, while gross profit as a percentage of sales
decreased to 20.2% compared to 21.4%;
- Adjusted EBITDA(1) decreased by $5.3 million, or 6.8%, to $73.2 million compared to $78.5 million, and Adjusted EBITDA as a
percentage of sales(1) decreased to 8.7% compared to
9.6%;
- Net income decreased by $18.3
million, or 42.0%, to $25.3
million compared to $43.6
million and diluted earnings per share ("EPS") decreased to
$0.73 per share compared to
$1.24 per share; and
- Adjusted Net Income(1) decreased by $8.0 million, or 20.3%, to $31.4 million compared to $39.4 million and Adjusted Diluted
EPS(1) decreased to $0.91
per share compared to $1.12 per
share.
Q3 Operational Update
In the third quarter, the Company's foodservice business
continued to deliver both market share gains and net sales growth.
The consistent performance in an increasingly dynamic market is a
result of broad-based gains across channels and species;
executional excellence in priority growth segments of long-term
care, quick service restaurants and casual dining; as well as a
focused portfolio of branded and value-added customer solutions.
The strength of High Liner Foods' foodservice business continued to
be supported by growth in our contract manufacturing and successful
targeted promotions and partnerships.
High Liner Foods' retail business continued to be impacted by
the slowdown in frozen seafood, protein categories and the grocery
channel overall across North
America driven by inflationary pressures on consumer
spending. The Company grew market share in Canada and maintained market share in the
US.
High Liner Foods is working closely with customers to invest in
supporting category growth and offer targeted customer promotions
to demonstrate the value and versatility of frozen seafood to
consumers.
Operationally, the Company's supply chain remains resilient in
the face of geopolitical pressures. However, the Company has
identified scope for improvements to plant efficiencies, and is
focused on ensuring appropriate alignment between operations,
inventory, and product mix to tighten efficiency and improve
margins.
"We are taking all available steps to support our customers and
consumers with a diversified portfolio of healthy and affordable
proteins. We are also continuing to refine our offering and ensure
that we support our enhanced sales approach and profitability with
optimization of our plant operations," Mr. Jewer concluded.
___________________________
|
(1) This is
a non-IFRS financial measure. For more information on non-IFRS
financial measures, see "Non-IFRS Measures" below and see "Non-IFRS
Financial Measures" in our Third Quarter 2023 Management's
Discussion and Analysis ("3Q2023 MD&A").
|
Financial Results
For the purpose of presenting the Consolidated Financial
Statements in USD, CAD-denominated assets and liabilities in the
Company's operations are converted using the exchange rate at the
reporting date, and revenue and expenses are converted at the
average exchange rate of the month in which the transaction occurs.
As such, foreign currency fluctuations affect the reported values
of individual lines on our balance sheet and income statement. When
the USD strengthens (weakening CAD), the reported USD values of the
Parent's CAD-denominated items decrease in the Consolidated
Financial Statements, and the opposite occurs when the USD weakens
(strengthening CAD).
Investors are reminded for purposes of calculating financial
ratios, including dividend payout and share price-to-earnings
ratios, to take into consideration that the Company's share price
and dividend rate are reported in CAD and its earnings, EPS and
financial statements are reported in USD.
The financial results in USD for the thirteen and thirty-nine
weeks ended September 30, 2023 and October 1, 2022 are
summarized in the following table:
|
Thirteen weeks
ended
|
Thirty-nine weeks
ended
|
(Amounts in 000s,
except per share amounts, unless otherwise noted)
|
September
30,
2023
|
October 1,
2022
|
September
30,
2023
|
October 1,
2022
|
Sales volume
(millions of lbs)
|
61.0
|
60.4
|
197.4
|
192.5
|
Average foreign
exchange rate (USD/CAD)
|
1.3414
|
1.3063
|
1.3456
|
1.2833
|
Sales
|
$
259,699
|
$
271,181
|
$
843,212
|
$
819,368
|
Gross
profit
|
$
49,644
|
$
56,747
|
$
170,032
|
$
175,090
|
Gross profit as a
percentage of sales
|
19.1 %
|
20.9 %
|
20.2 %
|
21.4 %
|
Adjusted
EBITDA
|
$
19,974
|
$
24,809
|
$
73,205
|
$
78,484
|
Adjusted EBITDA as a
percentage of sales
|
7.7 %
|
9.1 %
|
8.7 %
|
9.6 %
|
Net
income
|
$
5,486
|
$
9,977
|
$
25,261
|
$
43,599
|
Diluted
EPS
|
$
0.16
|
$
0.28
|
$
0.73
|
$
1.24
|
Adjusted Net
Income
|
$
4,906
|
$
14,292
|
$
31,387
|
$
39,395
|
Adjusted Diluted
EPS
|
$
0.14
|
$
0.41
|
$
0.91
|
$
1.12
|
Diluted weighted
average number of shares outstanding
|
34,001
|
35,102
|
34,092
|
35,141
|
Sales volume for the thirteen weeks ended September 30, 2023, or the third quarter of 2023,
increased by 0.6 million pounds, or 1.0%, to 61.0 million pounds
compared to 60.4 million pounds in the thirteen weeks ended
October 1, 2022 due to higher
volume in our foodservice business, partially offset by lower
volume in our retail business. In our foodservice business, sales
volume was higher due to increased contract manufacturing business,
increased sales in newer product lines, and improved customer
service levels. The Company achieved strong service levels during
the third quarter of 2023, as compared to the third quarter of 2022
due to the increased investment in working capital in the latter
part of Fiscal 2022 to mitigate the impact of the global supply
chain challenges. This was partially offset by lower sales volume
in our retail business due to the continued impact of inflation.
This resulted from softer demand for protein, including seafood
product as consumers switch to lower cost alternatives.
Sales in the third quarter of 2023 decreased by $11.5 million, or 4.2%, to $259.7 million compared to $271.2 million in the same period in 2022,
reflecting changes in sales mix and sharper pricing most notably on
some of our commodity products during the third quarter of fiscal
2023 compared to the inflationary environment in the same period
last year. This decrease was partially offset by higher sales
volumes mentioned previously and some inflationary-pricing actions
implemented during the last quarter of Fiscal 2022 and the first
quarter of 2023 which remained in effect during the third quarter
of Fiscal 2023. The weaker Canadian dollar in the first three
quarters of 2023 compared to the same quarter of 2022 decreased the
value of reported USD sales from our CAD-denominated operations by
approximately $1.7 million relative
to the conversion impact last year.
Gross profit in the third quarter of 2023 decreased by
$7.1 million to $49.6 million compared to $56.7 million in the same period in 2022 and
gross profit as a percentage of sales decreased by 180 basis points
to 19.1% compared to 20.9%. The decrease in gross profit reflects
changes in product mix, higher carrying costs associated with
higher inventory including sharper pricing on some of our commodity
products and some inefficiencies at our plants. The decrease in
gross profit was partially offset by the increase in sales volume
and inflationary-pricing actions on some products, both discussed
previously. In addition, the weaker Canadian dollar decreased
the value of reported USD gross profit from our CAD-denominated
operations by approximately $0.3
million relative to the conversion impact last year.
Adjusted EBITDA in the third quarter of 2023 decreased by
$4.8 million to $20.0 million compared to $24.8 million in the same period in 2022 and
Adjusted EBITDA as a percentage of sales decreased to 7.7% compared
to 9.1%. The decrease reflects the decrease in gross profit,
partially offset by the decrease in distribution costs and net
SG&A expenses.
Reported net income in the third quarter of 2023 decreased by
$4.5 million to net income of
$5.5 million (diluted EPS of
$0.16) compared to $10.0 million (diluted EPS of $0.28) in the same period in 2022. The decrease
in net income was due to the decrease in Adjusted EBITDA, an
increase in finance costs and income taxes in the third quarter of
2023 compared to the same period last year, partially offset by
lower share-based compensation expense.
Reported net income in the third quarter of 2023 and 2022
included certain non-routine expenses classified as "business
acquisition, integration and other expense (income)." Excluding the
impact of these non-routine items or other non-cash expenses, and
share-based compensation, Adjusted Net Income in the third quarter
of 2023 decreased by $9.4 million, or
65.7% to $4.9 million compared to
$14.3 million in the same period in
the prior year and Adjusted Diluted EPS decreased $0.27
in the third quarter of 2023 to $0.14
as compared to $0.41 in the same
period in the prior year.
Net cash flows provided by (used in) operating activities in the
third quarter of 2023 increased by $63.9
million to an inflow of $54.0
million compared to an outflow of $9.9 million in the same period in 2022 due to
favourable changes in non-cash working capital balances, partially
offset by lower cash flows provided by operations, and higher
interest paid during the third quarter of 2023. Capital
expenditures were $13.1
million in the first three quarters of 2023 compared to
$11.8 million in the prior year
reflecting the continued significant investment in the
business.
Net Debt decreased by $80.7
million to $304.8 million at
September 30, 2023 compared to $385.5
million at December 31, 2022, reflecting lower bank
loans and lower long-term debt, partially offset by higher lease
liabilities as at September 30, 2023, as compared to
December 31, 2022.
Net Debt to Rolling Twelve-Month Adjusted EBITDA was
3.1x at September 30, 2023 compared to 3.7x at the end of
Fiscal 2022 and 3.2x at October 1, 2022. Net Debt to
Rolling Twelve-Months Adjusted EBITDA increased during the second
half of Fiscal 2022 primarily as a result of increased investment
in working capital in Fiscal 2022 and inflation in raw materials.
In the absence of any major acquisitions or unplanned capital
expenditures in 2023, we expect this ratio to be in line with the
Company's long-term target of 3.0x at the end of Fiscal 2023.
Outlook
The Company remains confident in the long-term outlook for the
business and its ability to navigate current macro-economic
challenges. However, the Company anticipates that economic
conditions impacting consumer spending patterns with respect to
frozen seafood will continue to impact results in the
short-term.
As a result, High Liner Foods no longer anticipates
year-over-year Adjusted EBITDA growth for fiscal 2023. The Company
will continue to focus on improving working capital and generating
cash flow from operations. The Company maintains its confidence in
achieving the long-term leverage ratio of 3.0x.
The Company has a strong balance sheet and is well equipped to
invest in organic growth, explore opportunities for transformative
growth through potential M&A activities to build shareholder
value and continue to grow the dividend.
Conference Call
The Company will host a conference call on Thursday,
November 9, 2023, at 10:00 a.m.
ET (11:00 a.m. AT) during
which Paul Jewer, Interim Chief
Executive Officer and Anthony
Rasetta, Chief Commercial Officer, will discuss the
financial results for the third quarter of 2023. To access the
conference call by telephone, dial 416-764-8659 or 1-888-664-6392.
Please connect approximately 10 minutes prior to the beginning of
the call to ensure participation. The conference call will be
archived for replay by telephone until Sunday, December 10,
2023 at midnight (ET). To access the archived conference call, dial
1-888-390-0541 and enter the replay entry code 874664#.
A live audio webcast of the conference call will be available at
www.highlinerfoods.com. Please connect at least 15 minutes prior to
the conference call to ensure adequate time for any software
download that may be required to join the webcast.
The Company's Unaudited Condensed Interim Consolidated Financial
Statements and MD&A as at and for the thirteen and thirty-nine
weeks ended September 30, 2023 were filed concurrently on
SEDAR Plus with this news release and are also available at
www.highlinerfoods.com.
Non-IFRS Measures
The Company reports its financial results in accordance with
International Financial Reporting Standards ("IFRS"). Included in
this media release are the following non-IFRS financial measures:
Adjusted EBITDA, Adjusted EBITDA as a Percentage of Net Sales,
Adjusted Net Income, Adjusted Diluted EPS, Net Debt and Net Debt to
Rolling Twelve-Month Adjusted EBITDA.
The Company believes these non-IFRS financial measures provide
useful information to both management and investors in measuring
the financial performance and financial condition of the Company
for the reasons outlined below. These measures do not have any
standardized meaning as prescribed by IFRS and therefore may not be
comparable to similarly titled measures presented by other publicly
traded companies, nor should they be construed as an alternative to
other financial measures determined in accordance with
IFRS.
Adjusted EBITDA and Adjusted EBITDA as a Percentage of
Sales
Adjusted EBITDA is defined as earnings before interest, taxes,
depreciation and amortization adjusted for items that are not
considered representative of ongoing operational activities of the
business. The related margin, Adjusted EBITDA as a Percentage of
Sales, is defined as Adjusted EBITDA divided by net sales, where
net sales is defined as "Sales" on the consolidated statements of
income.
We use Adjusted EBITDA (and Adjusted EBITDA as a percentage of
sales) as a performance measure as it approximates cash generated
from operations before capital expenditures and changes in working
capital, and it excludes the impact of expenses and recoveries
associated with certain non-routine items that are not considered
representative of the ongoing operational activities, as discussed
above, and share-based compensation expense related to the
Company's share price. For the thirty-nine weeks ended October 1, 2022, Adjusted EBITDA also excludes
the $10.0 million in insurance
proceeds. We believe investors and analysts also use Adjusted
EBITDA (and Adjusted EBITDA as a percentage of sales) to evaluate
the performance of our business. The most directly comparable IFRS
measure to Adjusted EBITDA is "Net income" on the consolidated
statements of income. Adjusted EBITDA is also useful when comparing
to other companies, as it eliminates the differences in earnings
that are due to how a company is financed. Also, for the purpose of
certain covenants on our credit facilities, "EBITDA" is based on
Adjusted EBITDA, with further adjustments as defined in the
Company's credit agreements.
The following table reconciles Adjusted EBITDA with measures
that are found in our Consolidated Financial Statements, and
calculates Adjusted EBITDA as a Percentage of Sales.
|
|
|
|
Thirteen weeks
ended
|
(Amounts in
$000s)
|
|
September 30,
2023
|
|
October 1,
2022
|
Net
income
|
|
$
5,486
|
|
$
9,977
|
Add back
(deduct):
|
|
|
|
|
Depreciation and
amortization expense
|
|
6,367
|
|
6,045
|
Finance
costs
|
|
6,502
|
|
4,710
|
Income tax
expense
|
|
2,044
|
|
1,711
|
Standardized
EBITDA
|
|
20,399
|
|
22,443
|
Add back
(deduct):
|
|
|
|
|
Business acquisition,
integration and other expenses (income)
|
|
1,044
|
|
648
|
Impairment of
property, plant and equipment
|
|
—
|
|
117
|
Loss on disposal of
assets
|
|
133
|
|
119
|
Share-based
compensation (recovery) expense
|
|
(1,602)
|
|
1,482
|
Adjusted
EBITDA
|
|
$
19,974
|
|
$
24,809
|
Net
Sales
|
|
$
259,699
|
|
$
271,181
|
Adjusted EBITDA as
Percentage of Sales
|
|
7.7 %
|
|
9.1 %
|
|
|
|
|
Thirty-nine weeks
ended
|
(Amounts in
$000s)
|
|
September 30,
2023
|
|
October 1,
2022
|
Net
income
|
|
$
25,261
|
|
$
43,599
|
Add back
(deduct):
|
|
|
|
|
Depreciation and
amortization expense
|
|
18,396
|
|
17,408
|
Finance
costs
|
|
20,361
|
|
12,310
|
Income tax
expense
|
|
1,768
|
|
10,787
|
Standardized
EBITDA
|
|
65,786
|
|
84,104
|
Add back
(deduct):
|
|
|
|
|
Business acquisition,
integration and other expenses (income)(1)
|
|
6,660
|
|
(8,118)
|
Impairment of
property, plant and equipment
|
|
—
|
|
168
|
(Gain) loss on
disposal of assets
|
|
(42)
|
|
135
|
Share-based
compensation expense
|
|
801
|
|
2,195
|
Adjusted
EBITDA
|
|
$
73,205
|
|
$
78,484
|
Net
Sales
|
|
$
843,212
|
|
$
819,368
|
Adjusted EBITDA as a
Percentage of Sales
|
|
8.7 %
|
|
9.6 %
|
(1) The
business acquisition, integration and other expenses (income) for
the thirty-nine weeks ended October 1, 2022, includes
insurance proceeds of $10.0 million which is excluded in Adjusted
EBITDA.
|
Rolling Twelve-Month Adjusted EBITDA
|
Rolling twelve
months ended
|
(Amounts in
$000s)
|
September
30,
2023
|
December 31,
2022
|
October 1,
2022
|
Net
income
|
$
36,392
|
$
54,730
|
$
50,822
|
Add back
(deduct):
|
|
|
|
Depreciation and
amortization expense
|
24,566
|
23,578
|
23,178
|
Finance
costs
|
26,312
|
18,261
|
16,014
|
Income tax
expense
|
2,075
|
11,094
|
12,120
|
Standardized
EBITDA
|
89,345
|
107,663
|
102,134
|
Add back
(deduct):
|
|
|
|
Business acquisition,
integration and other (income) expenses(1)
|
7,605
|
(7,173)
|
(7,597)
|
Impairment of property,
plant and equipment
|
164
|
332
|
168
|
Loss on disposal of
assets
|
(12)
|
163
|
200
|
Share-based
compensation expense
|
1,488
|
2,882
|
4,177
|
Rolling Twelve-Month
Adjusted EBITDA
|
$
98,590
|
$
103,867
|
$
99,082
|
(1) The
business acquisition, integration and other expenses (income) for
the rolling twelve months ended December 31, 2022 and
October 1, 2022, included insurance proceeds of $10.0 million
which was excluded in Adjusted EBITDA
|
Adjusted Net Income and Adjusted Diluted EPS
Adjusted Net Income is net income adjusted for the after-tax
impact of items which are not representative of ongoing operational
activities of the business and certain non-cash expenses or income.
Adjusted Diluted EPS is Adjusted Net Income divided by the average
diluted number of shares outstanding.
We use Adjusted Net Income and Adjusted Diluted EPS to assess
the performance of our business without the effects of the
above-mentioned items, and we believe our investors and analysts
also use these measures. We exclude these items because they affect
the comparability of our financial results and could potentially
distort the analysis of trends in business performance. For the
thirty-nine weeks ended October 1, 2022, Adjusted Net Income
also excludes the $10.0 million in
insurance proceeds. The most comparable IFRS financial measures are
net income and EPS.
The table below reconciles our Adjusted Net Income with measures
that are found in our Consolidated Financial Statements and
calculates Adjusted Diluted EPS.
|
|
|
|
Thirteen weeks
ended
|
|
|
|
September 30,
2023
|
|
October 1,
2022
|
|
|
|
$000s
|
|
Adjusted
Diluted EPS
|
|
$000s
|
|
Adjusted
Diluted EPS
|
|
Net
income
|
|
$
5,486
|
|
$
0.16
|
|
$
9,977
|
|
$
0.28
|
|
Add back
(deduct):
|
|
|
|
|
|
|
|
|
|
Business acquisition,
integration and other (income) expenses
|
|
1,044
|
|
0.03
|
|
648
|
|
0.02
|
|
Impairment of
property, plant and equipment
|
|
—
|
|
—
|
|
117
|
|
—
|
|
Share-based
compensation (recovery) expense
|
|
(1,602)
|
|
(0.05)
|
|
1,482
|
|
0.05
|
|
Tax impact of
reconciling items (1)
|
|
(22)
|
|
—
|
|
2,068
|
|
0.06
|
|
Adjusted Net
Income
|
|
$
4,906
|
|
$
0.14
|
|
$
14,292
|
|
$
0.41
|
|
Average shares for
the period (000s)
|
|
|
|
34,001
|
|
|
|
35,102
|
|
|
|
|
|
Thirty-nine weeks
ended
|
|
|
September 30,
2023
|
|
October 1,
2022
|
|
|
$000s
|
|
Adjusted
Diluted EPS
|
|
$000s
|
|
Adjusted
Diluted EPS
|
Net
income
|
|
$
25,261
|
|
$
0.73
|
|
$
43,599
|
|
$
1.24
|
Add back
(deduct):
|
|
|
|
|
|
|
|
|
Business acquisition,
integration and other (income) expenses (2)
|
|
6,660
|
|
0.19
|
|
(8,118)
|
|
(0.23)
|
Impairment of
property, plant and equipment
|
|
—
|
|
—
|
|
168
|
|
—
|
Share-based
compensation expense
|
|
801
|
|
0.02
|
|
2,195
|
|
0.06
|
Tax impact of
reconciling items (1)
|
|
(1,335)
|
|
(0.03)
|
|
1,551
|
|
0.05
|
Adjusted Net
Income
|
|
$
31,387
|
|
$
0.91
|
|
$
39,395
|
|
$
1.12
|
Average shares for
the period (000s)
|
|
|
|
34,092
|
|
|
|
35,141
|
(1) The tax
impact of reconciling items includes the tax impact of the
insurance proceeds of $10.0 million received during the second
quarter of fiscal 2022 which is excluded in Adjusted Net
Income.
|
(2)The
business acquisition, integration and other expenses (income) for
the thirty-nine weeks ended October 1, 2022,
includes insurance proceeds of $10.0 million which is excluded in
Adjusted Net Income.
|
Net Debt and Net Debt to Rolling Twelve-Month Adjusted
EBITDA
Net Debt is calculated as the sum of bank loans, long-term debt
(excluding deferred finance costs and modification gains/losses)
and lease liabilities, less cash.
We consider Net Debt to be an important indicator of our
Company's financial leverage because it represents the amount of
debt that is not covered by available cash. We believe investors
and analysts use Net Debt to determine the Company's financial
leverage. Net Debt has no comparable IFRS financial measure, but
rather is calculated using several asset and liability items in the
consolidated statements of financial position.
Net Debt to Rolling Twelve-Month Adjusted EBITDA is calculated
as Net Debt divided by Rolling Twelve-Month Adjusted
EBITDA (see above). We consider Net Debt to Rolling
Twelve-Month Adjusted EBITDA to be an important indicator of our
ability to generate earnings sufficient to service our debt, that
enhances understanding of our financial performance and highlights
operational trends. This measure is widely used by investors and
rating agencies in the valuation, comparison, rating and investment
recommendations of companies; however, the calculations of Adjusted
EBITDA may not be comparable to those of other companies, which
limits their usefulness as comparative measures.
The following table reconciles Net Debt to IFRS measures
reported as at the end of the indicated periods in the consolidated
statements of financial position and calculates Net Debt to Rolling
Twelve-Month Adjusted EBITDA.
(Amounts in
$000s)
|
September
30,
2023
|
December 31,
2022
|
October 1,
2022
|
Bank loans
|
$
47,307
|
$
127,554
|
$
59,358
|
Add-back: Deferred
finance costs included in bank loans (1)
|
475
|
574
|
642
|
Total bank
loans
|
47,782
|
128,128
|
60,000
|
Long-term
debt
|
233,490
|
238,200
|
240,109
|
Current portion of
long-term debt
|
7,500
|
7,500
|
7,500
|
Add-back: Deferred
finance costs included in long-term debt (2)
|
3,945
|
4,972
|
4,974
|
Less: Net loss on
modification of debt (3)
|
(430)
|
(542)
|
(577)
|
Total term loan
debt
|
244,505
|
250,130
|
252,006
|
Long-term portion of
lease liabilities
|
7,893
|
2,813
|
3,859
|
Current portion of
lease liabilities
|
4,791
|
4,622
|
4,548
|
Total lease
liabilities
|
12,684
|
7,435
|
8,407
|
Less: Cash
|
(183)
|
(155)
|
(3,339)
|
Net
Debt
|
$
304,788
|
$
385,538
|
$
317,074
|
Rolling Twelve-Month
Adjusted EBITDA
|
$
98,590
|
$
103,867
|
$
99,082
|
Net Debt to Rolling
Twelve-Month Adjusted EBITDA
|
3.1x
|
3.7x
|
3.2x
|
(1)
Represents deferred finance costs that are included in "Bank loans"
in the consolidated statements of financial position. See Note 3 to
the Consolidated Financial Statements.
|
(2) Represents deferred finance costs
that are included in "Long-term debt" in the consolidated
statements of financial position. See Note 4 to the Consolidated
Financial Statements.
|
(3) A
gain on modification of debt related to the refinancing completed
in March 2021, has been excluded from the calculation of Net Debt
as it does not represent the expected cash outflows from the term
loan facility.
|
Forward Looking Statements
Forward-looking statements can generally be identified by the
use of the conditional tense, the words "may", "should", "would",
"could", "believe", "plan", "expect", "intend", "anticipate",
"estimate", "foresee", "objective", "goal", "remain" or "continue"
or the negative of these terms or variations of them or words and
expressions of similar nature. Actual results could differ
materially from the conclusion, forecast or projection stated in
such forward-looking information. As a result, we cannot guarantee
that any forward-looking statements will materialize. Assumptions,
expectations and estimates made in the preparation of
forward-looking statements and risks that could cause our actual
results to differ materially from our current expectations are
discussed in detail in the Company's materials filed with the
Canadian securities regulatory authorities from time to time,
including the Risk Factors section of our MD&A for the
thirteen and thirty-nine weeks ended September 30, 2023, the Risk Factors section of
our 2022 MD&A and the Risk Factors section of our 2022 Annual
Information Form. The risks and uncertainties that may affect the
operations, performance, development and results of High Liner
Foods' business include, but are not limited to, the following
factors: compliance with food safety laws and regulations; timely
identification of and response to events that could lead to a
product recall; volatility in the CAD/USD exchange rate;
competitive developments including increases in overseas seafood
production and industry consolidation; availability and price of
seafood raw materials and finished goods and the impact of
geopolitical events (and related economic sanctions) on the same;
the impact of the U.S. Trade Representative's tariffs on certain
seafood products; costs of commodity products, freight, storage and
other production inputs, and the ability to pass cost increases on
to customers; successful integration of acquired operations;
potential increases in maintenance and operating costs; shifts in
market demands for seafood; performance of new products launched
and existing products in the market place; changes in laws and
regulations, including environmental, taxation and regulatory
requirements; technology changes with respect to production and
other equipment and software programs; enterprise resource planning
system risk; adverse impacts of cybersecurity attacks or breach of
sensitive information; supplier fulfillment of contractual
agreements and obligations; competitor reactions; completion and/or
advancement of sustainability initiatives, including, without
limitation, initiatives relating to the carbon work plan, carbon
reduction initiatives and potential failure to meet such carbon
reduction targets; the uncertainty of final results related to
litigation and/or arbitration, including net amounts to be received
by the Company and whether such amounts may be subject to
subrogation rights by applicable insurers; waste reduction and/or
seafood sustainability and traceability initiatives; High Liner
Foods' ability to generate adequate cash flow or to finance its
future business requirements through outside sources; credit risk
associated with receivables from customers; volatility associated
with the funding status of the Company's post-retirement pension
benefits; adverse weather conditions and natural disasters; the
availability of adequate levels of insurance; management retention
and development; economic and geopolitical conditions such as
Russia's invasion of Ukraine and the implementation and/or
expansion of related sanctions policies; and the potential impact
of a pandemic outbreak of a contagious illness, such as COVID-19
pandemic, on general economic and business conditions and therefore
the Company's operations and financial performance. Forward-looking
information is based on management's current estimates,
expectations and assumptions, which we believe are reasonable as of
the current date. You should not place undue importance on
forward-looking information and should not rely upon this
information as of any other date. Except as required under
applicable securities laws, we do not undertake to update these
forward-looking statements, whether written or oral, that may be
made from time to time by us or on our behalf, whether as a result
of new information, future events or otherwise. We include in
publicly available documents filed from time to time with
securities commissions and The Toronto Stock Exchange, a discussion
of the risk factors that can cause anticipated outcomes to differ
from actual outcomes. Except as required under applicable
securities legislation, we do not undertake to update
forward-looking statements, whether written or oral, that may be
made from time to time by us or on our behalf, whether as a result
of new information, future events or otherwise.
About High Liner Foods Incorporated
High Liner Foods Incorporated is a leading North American
processor and marketer of value-added frozen seafood. High Liner
Foods' retail branded products are sold throughout the United States and Canada under the High Liner,
Fisher Boy, Mirabel, Sea Cuisine,
and Catch of the Day labels, and are available in
most grocery and club stores. The Company also sells branded
products to restaurants and institutions under the High
Liner, Mirabel, Icelandic
Seafood and FPI labels and is a major
supplier of private label value-added seafood products to North
American food retailers and foodservice distributors. High Liner
Foods is a publicly traded Canadian company, trading under the
symbol HLF on the Toronto Stock Exchange.
For further information about the Company, please visit our
website at www.highlinerfoods.com or send an e-mail to
investor@highlinerfoods.com.
SOURCE High Liner Foods Incorporated